AU2267992A - Compounds used for the inhibition of hiv-protease - Google Patents

Compounds used for the inhibition of hiv-protease

Info

Publication number
AU2267992A
AU2267992A AU22679/92A AU2267992A AU2267992A AU 2267992 A AU2267992 A AU 2267992A AU 22679/92 A AU22679/92 A AU 22679/92A AU 2267992 A AU2267992 A AU 2267992A AU 2267992 A AU2267992 A AU 2267992A
Authority
AU
Australia
Prior art keywords
hiv
protease
inhibition
compounds used
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22679/92A
Inventor
Michael John Bohanon
Joyce Irma Cialdella
Lester Arthur Dolak
Grace P Li
Eric Peter Seest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AU2267992A publication Critical patent/AU2267992A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/22—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings
    • C07C305/24—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60—Two oxygen atoms, e.g. succinic anhydride
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P11/00—Preparation of sulfur-containing organic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU22679/92A 1991-08-27 1992-06-29 Compounds used for the inhibition of hiv-protease Abandoned AU2267992A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75017991A 1991-08-27 1991-08-27
US750179 1991-08-27

Publications (1)

Publication Number Publication Date
AU2267992A true AU2267992A (en) 1993-03-16

Family

ID=25016825

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22679/92A Abandoned AU2267992A (en) 1991-08-27 1992-06-29 Compounds used for the inhibition of hiv-protease

Country Status (2)

Country Link
AU (1) AU2267992A (en)
WO (1) WO1993004055A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0626178A1 (en) * 1993-05-17 1994-11-30 Ciba-Geigy Ag Use of inhibitors of HIV-protease for the treatment of tumorous diseases
TW354294B (en) * 1993-09-17 1999-03-11 Upjohn Co Substituted tetronic acids useful for treating HIV and other retroviruses
AU5417696A (en) * 1995-03-20 1996-10-08 Upjohn Company, The Substituted tetronic acids useful for treating hiv and other retroviruses
EP4076437A1 (en) * 2019-12-16 2022-10-26 The Regents Of The University Of Michigan Inhibitors of mhc-i nef downmodulation for treating hiv

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA852614B (en) * 1985-05-17 1986-10-09 Takeda Chemical Industries, Ltd. Ascorbic acid ethers and their production
JP2765001B2 (en) * 1988-02-23 1998-06-11 武田薬品工業株式会社 Protease inhibitor
US5045458A (en) * 1988-10-20 1991-09-03 Shionogi & Co., Ltd. Antibiotics PB-6042S
EP0480624A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. Inhibitors of HIV protease

Also Published As

Publication number Publication date
WO1993004055A2 (en) 1993-03-04
WO1993004055A3 (en) 1993-04-29

Similar Documents

Publication Publication Date Title
AU657350B2 (en) Heterocyclic compounds
AU2056992A (en) Heterocyclic compounds
AU3629693A (en) Heterobicyclic compounds
AU1704492A (en) Chemical compounds
AU1168495A (en) Chemical compounds
AU1513092A (en) Dehalogenation of organohalogen-containing compounds
AU8551191A (en) Inhibition of scale
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU5033293A (en) Process for the preparation of aromatic bromomethyl compounds
AU1975092A (en) Compounds
AU2156192A (en) Chemical compounds
GB9124733D0 (en) Derivatives of poly-4-amino-2-carboxy-1-methyl compounds
AU5188093A (en) Fungicidal derivatives of 2-alkoxy-2-imidazolin-5-ones
AU5184393A (en) Substituted derivatives of diaminophthalimide
NO920049D0 (en) PROCEDURE FOR THE PREPARATION OF 3-EXOMETHYLENEFAMSULPHOX ESTEXTS
AU1142192A (en) Process for the preparation of 13c-labelled compounds
AU8463691A (en) Processes for the preparation of nitrogen-containing compounds
AU4712696A (en) The use of heterocyclic compounds
AU2267992A (en) Compounds used for the inhibition of hiv-protease
AU2894492A (en) Heterocyclic compounds
AU5217693A (en) Apparatus for the manufacture of tinplates
AU1500992A (en) Pharmaceutical compound
AU1554492A (en) Triazole compounds
EP0537589A3 (en) Process for the preparation of dinitro- and diaminophenoxy compounds
AU5922994A (en) Oxazinobenzazole compounds